Efficacy and Safety of Lapaquistat Acetate Coadministered With Atorvastatin in Subjects With Hypercholesterolemia
Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of lapaquistat acetate, once daily
(QD), coadministered with a statin to lower lipid levels in Subjects with
Hypercholesterolemia.